Strength in numbers: Antifungal strategies against fungal biofilms

International Journal of Antimicrobial Agents

Volumn 43, Issue 2, 2014, Pages 114-120

  Ramage, Gordon ^a   Robertson, Shaun N ^a,b   Williams, Craig ^b  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

Antifungal; Biofilm; Candida; Echinocandin; Liposomal amphotericin B

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL THERAPY; ASPERGILLOSIS; BIOFILM; CANDIDA ALBICANS; CANDIDIASIS; CATHETER INFECTION; CATHETER REMOVAL; CRYPTOCOCCOSIS; DISEASE CARRIER; DRUG EFFICACY; FUNGAL BIOFILM; FUNGUS TRANSMISSION; HOSPITAL INFECTION; HUMAN; MORTALITY; NONHUMAN; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; REVIEW; THRUSH;

ANTIFUNGAL; BIOFILM; CANDIDA; ECHINOCANDIN; LIPOSOMAL AMPHOTERICIN B;

ANTIFUNGAL AGENTS; BIOFILMS; FUNGI; HUMANS;

EID: 84893651400     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.10.023     Document Type: Short Survey

References (148)

1. R.M. Donlan, and J.W. Costerton Biofilms: survival mechanisms of clinically relevant microorganisms Clin Microbiol Rev 15 2002 167 193
2. G. Ramage, and C. Williams The clinical importance of fungal biofilms Adv Appl Microbiol 84 2013 27 83
3. G. Ramage, R. Rajendran, L. Sherry, and C. Williams Fungal biofilm resistance Int J Microbiol 2012 2012 528521
4. J.S. Finkel, and A.P. Mitchell Genetic control of Candida albicans biofilm development Nat Rev Microbiol 9 2011 109 118
5. G. Ramage, R. Rajendran, M. Gutierrez-Correa, B. Jones, and C. Williams Aspergillus biofilms: clinical and industrial significance FEMS Microbiol Lett 324 2011 89 97
6. J. Bonhomme, and C. d'Enfert Candida albicans biofilms: building a heterogeneous, drug-tolerant environment Curr Opin Microbiol 16 2013 398 403
7. R. Rautemaa, and G. Ramage Oral candidosis - clinical challenges of a biofilm disease Crit Rev Microbiol 37 2011 328 336
8. G. Ramage, K. Tomsett, B.L. Wickes, J.L. López-Ribot, and S.W. Redding Denture stomatitis: a role for Candida biofilms Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 2004 53 59
9. G. Ramage, B. Coco, L. Sherry, J. Bagg, and D.F. Lappin In vitro Candida albicans biofilm induced proteinase activity and SAP8 expression correlates with in vivo denture stomatitis severity Mycopathologia 174 2012 11 19
10. S. Silva, M. Henriques, A. Hayes, R. Oliveira, J. Azeredo, and D.W. Williams Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium J Oral Pathol Med 40 2011 421 427
11. P. Grosjean, and R. Weber Fungus balls of the paranasal sinuses: a review Eur Arch Otorhinolaryngol 264 2007 461 470
12. A. Karkas, R. Rtail, E. Reyt, N. Timi, and C.A. Righini Sphenoid sinus fungus ball Eur Arch Otorhinolaryngol 270 2013 893 898
13. M.W. Harding, L.L. Marques, R.J. Howard, and M.E. Olson Can filamentous fungi form biofilms? Trends Microbiol 17 2009 475 480
14. E. Mowat, C. Williams, B. Jones, S. McChlery, and G. Ramage The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm? Med Mycol 47 Suppl. 1 2009 S120 S126
15. F.R. Sato, R. Sawazaki, D. Berretta, R.W. Moreira, P.A. Vargas, and O.P. de Almeida Aspergillosis of the maxillary sinus associated with a zygomatic implant J Am Dent Assoc 141 2010 1231 1235
16. K.J. Buijssen, B.F. van der Laan, H.C. van der Mei, J. Atema-Smit, P. van den Huijssen, and H.J. Busscher et al. Composition and architecture of biofilms on used voice prostheses Head Neck 34 2012 863 871
17. S.R. Ell Candida - 'the cancer of silastic' J Laryngol Otol 110 1996 240 242
18. G.J. Elving, H.C. van Der Mei, H.J. Busscher, R. van Weissenbruch, and F.W. Albers Air-flow resistances of silicone rubber voice prostheses after formation of bacterial and fungal biofilms J Biomed Mater Res 58 2001 421 426
19. S.I. Sayed, S. Datta, N. Deore, R.A. Kazi, and M.V. Jagade Prevention of voice prosthesis biofilms: current scenario and future trends in prolonging prosthesis lifetime J Indian Med Assoc 110 2012 175 178 180
20. M.S. Delisle, D.R. Williamson, M. Albert, M.M. Perreault, X. Jiang, and A.G. Day et al. Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia Can Respir J 18 2011 131 136
21. K. Stonecypher Ventilator-associated pneumonia: the importance of oral care in intubated adults Crit Care Nurs Q 33 2010 339 347
22. R.A. Caserta, A.R. Marra, M.S. Durão, C.V. Silva, O.F. Pavao Dos Santos, and H.S. Neves et al. A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting BMC Infect Dis 12 2012 234
23. D.W. Denning Invasive aspergillosis Clin Infect Dis 26 1998 781 803
24. R.S. Jayshree, M. Shafiulla, J. George, J.K. David, P.P. Bapsy, and A. Chakrabarti Microscopic, cultural and molecular evidence of disseminated invasive aspergillosis involving the lungs and the gastrointestinal tract J Med Microbiol 55 2006 961 964
25. R.C. Young, J.E. Bennett, C.L. Vogel, P.P. Carbone, and V.T. DeVita Aspergillosis. The spectrum of the disease in 98 patients Medicine (Baltimore) 49 1970 147 173
26. L. Muszkieta, A. Beauvais, V. Pahtz, J.G. Gibbons, V. Anton Leberre, and R. Beau et al. Investigation of Aspergillus fumigatus biofilm formation by various 'omics' approaches Front Microbiol 4 2013 13
27. C.C. Blyth, P.G. Middleton, A. Harun, T.C. Sorrell, W. Meyer, and S.C. Chen Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors? Med Mycol 48 Suppl. 1 2010 S37 S44
28. B. Cimon, J. Carrère, J.F. Vinatier, J.P. Chazalette, D. Chabasse, and J.P. Bouchara Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis Eur J Clin Microbiol Infect Dis 19 2000 53 56
29. N. Kondori, M. Gilljam, A. Lindblad, B. Jönsson, E.R. Moore, and C. Wenneras High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency J Clin Microbiol 49 2011 1004 1009
30. L. Delhaes, S. Monchy, E. Fréalle, C. Hubans, J. Salleron, and S. Leroy et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community - implications for therapeutic management PLoS ONE 7 2012 e36313
31. S. Macfarlane, and J.F. Dillon Microbial biofilms in the human gastrointestinal tract J Appl Microbiol 102 2007 1187 1196
32. C.J. Damman, S.I. Miller, C.M. Surawicz, and T.L. Zisman The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 107 2012 1452 1459
33. L. Trevisani, S. Sartori, M.R. Rossi, R. Bovolenta, M. Scoponi, and S. Gullini et al. Degradation of polyurethane gastrostomy devices: what is the role of fungal colonization? Dig Dis Sci 50 2005 463 469
34. K. Gottlieb, J. Leya, D.M. Kruss, S. Mobarhan, and F.L. Iber Intraluminal fungal colonization of gastrostomy tubes Gastrointest Endosc 39 1993 413 415
35. C.A. Kumamoto Inflammation and gastrointestinal Candida colonization Curr Opin Microbiol 14 2011 386 391
36. C.A. Kauffman, J.F. Fisher, J.D. Sobel, and C.A. Newman Candida urinary tract infections - diagnosis Clin Infect Dis 52 Suppl. 6 2011 S452 S456
37. J.D. Sobel, J.F. Fisher, C.A. Kauffman, and C.A. Newman Candida urinary tract infections - epidemiology Clin Infect Dis 52 Suppl. 6 2011 S433 S436
38. G. Reid, J.D. Denstedt, Y.S. Kang, D. Lam, and C. Nause Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo J Urol 148 1992 1592 1594
39. S.P. Yang, Y.Y. Chen, H.S. Hsu, F.D. Wang, L.Y. Chen, and C.P. Fung A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study BMC Infect Dis 13 2013 10
40. S.W. Lee An aspergilloma mistaken for a pelviureteral stone on non-enhanced CT: a fungal bezoar causing ureteral obstruction Korean J Urol 51 2010 216 218
41. F.M. Muller, M. Seidler, and A. Beauvais Aspergillus fumigatus biofilms in the clinical setting Med Mycol 49 Suppl. 1 2011 S96 S100
42. L.K. Branski, A. Al-Mousawi, H. Rivero, M.G. Jeschke, A.P. Sanford, and D.N. Herndon Emerging infections in burns Surg Infect (Larchmt) 10 2009 389 397
43. J.L. Leake, S.E. Dowd, R.D. Wolcott, and A.M. Zischkau Identification of yeast in chronic wounds using new pathogen-detection technologies J Wound Care 18 2009 103 108
44. T. Warkentien, C. Rodriguez, B. Lloyd, J. Wells, A. Weintrob, and J.R. Dunne et al. Invasive mold infections following combat-related injuries Clin Infect Dis 55 2012 1441 1449
45. K.M. Paolino, J.A. Henry, D.R. Hospenthal, G.W. Wortmann, and J.D. Hartzell Invasive fungal infections following combat-related injury Mil Med 177 2012 681 685
46. S.E. Dowd, J. Delton Hanson, E. Rees, R.D. Wolcott, A.M. Zischau, and Y. Sun et al. Survey of fungi and yeast in polymicrobial infections in chronic wounds J Wound Care 20 2011 40 47
47. F. Odds Candida and candidosis 2nd ed. 1988 Bailliere Tindall London, UK
48. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317
49. M. Kollef, S. Micek, N. Hampton, J.A. Doherty, and A. Kumar Septic shock attributed to Candida infection: importance of empiric therapy and source control Clin Infect Dis 54 2012 1739 1746
50. D.R. Andes, N. Safdar, J.W. Baddley, G. Playford, A.C. Reboli, and J.H. Rex et al. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials Clin Infect Dis 54 2012 1110 1122
51. P. Uppuluri, A.K. Chaturvedi, A. Srinivasan, M. Banerjee, A.K. Ramasubramaniam, and J.R. Kohler et al. Dispersion as an important step in the Candida albicans biofilm developmental cycle PLoS Pathog 6 2010 e1000828
52. M. Tumbarello, B. Posteraro, E.M. Trecarichi, B. Fiori, M. Rossi, and R. Porta et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia J Clin Microbiol 45 2007 1843 1850
53. M. Tumbarello, B. Fiori, E.M. Trecarichi, P. Posteraro, A.R. Losito, and A. De Luca et al. Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital PLoS ONE 7 2012 e33705
54. S. Pannanusorn, V. Fernandez, and U. Romling Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection Mycoses 56 2013 264 272
55. M. Valdivieso, M. Luna, G.P. Bodey, V. Rodriguez, and D. Groschel Fungemia due to Torulopsis glabrata in the compromised host Cancer 38 1976 1750 1756
56. J. Fortún, P. Martín-Dávila, E. Gómez- García de la Pedrosa, V. Pintado, J. Cobo, and G. Fresco et al. Emerging trends in candidemia: a higher incidence but a similar outcome J Infect 65 2012 64 70
57. C. Paige, C.W. Pinson, R. Antonovic, and L.J. Strausbaugh Catheter-related thrombophlebitis of the superior vena cava caused by Candida glabrata West J Med 147 1987 333 335
58. S.V. Komshian, A.K. Uwaydah, J.D. Sobel, and L.R. Crane Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome Rev Infect Dis 11 1989 379 390
59. E.B. Walter Jr., J.L. Gingras, and R.E. McKinney Jr. Systemic Torulopsis glabrata infection in a neonate South Med J 83 1990 837 838
60. D.K. Heffner, and W.A. Franklin Endocarditis caused by Torulopsis glabrata Am J Clin Pathol 70 1978 420 423
61. J.S. Goodman, D.G. Seibert, G.E. Reahl Jr., and R.W. Geckler Fungal infection of prosthetic joints: a report of two cases J Rheumatol 10 1983 494 495
62. E. Cecchin, S. De Marchi, G. Panarello, A. Franceschin, V. Chiaradia, and G. Santini et al. Torulopsis glabrata peritonitis complicating continuous ambulatory peritoneal dialysis: successful management with oral 5-fluorocytosine Am J Kidney Dis 4 1984 280 284
63. M. Pammi, L. Holland, G. Butler, A. Gacser, and J.M. Bliss Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis Pediatr Infect Dis J 32 2013 206 216
64. M. Wada, H. Baba, and S. Imura Prosthetic knee Candida parapsilosis infection J Arthroplasty 13 1998 479 482
65. P.M. Fox, and G.K. Lee Tissue expander with acellular dermal matrix for breast reconstruction infected by an unusual pathogen: Candida parapsilosis J Plast Reconstr Aesthet Surg 65 2012 e286 e289
66. S. Younkin, C.M. Evarts, and R.T. Steigbigel Candida parapsilosis infection of a total hip-joint replacement: successful reimplantation after treatment with amphotericin B and 5-fluorocytosine. A case report J Bone Joint Surg Am 66 1984 142 143
67. F.T. Cannizzo, E. Eraso, P.A. Ezkurra, M. Villar-Vidal, E. Bollo, and G. Castellá et al. Biofilm development by clinical isolates of Malassezia pachydermatis Med Mycol 45 2007 357 361
68. D. D'Antonio, G. Parruti, E. Pontieri, G. Di Bonaventura, L. Manzoli, and R. Sferra et al. Slime production by clinical isolates of Blastoschizomyces capitatus from patients with hematological malignancies and catheter-related fungemia Eur J Clin Microbiol Infect Dis 23 2004 787 789
69. R. Singh, M.R. Shivaprakash, and A. Chakrabarti Biofilm formation by zygomycetes: quantification, structure and matrix composition Microbiology 157 2011 2611 2618
70. T.J. Walsh, R. Schlegel, M.M. Moody, J.W. Costerton, and M. Salcman Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study Neurosurgery 18 1986 373 375
71. P. Langer, R.A. Kassim, G.S. Macari, and K.J. Saleh Aspergillus infection after total knee arthroplasty Am J Orthop (Belle Mead, NJ) 32 2003 402 404
72. W.B. Rosenblatt, and A. Pollock Aspergillus flavus cultured from a saline-filled implant Plast Reconstr Surg 99 1997 1470 1472
73. T.K. Jeloka, S. Shrividya, and G. Wagholikar Catheter outflow obstruction due to an aspergilloma Perit Dial Int 31 2011 211 212
74. W. Escande, G. Fayad, T. Modine, E. Verbrugge, M. Koussa, and E. Senneville et al. Culture of a prosthetic valve excised for streptococcal endocarditis positive for Aspergillus fumigatus 20 years after previous A. fumigatus endocarditis Ann Thorac Surg 91 2011 e92 e93
75. R. Golmia, I. Bello, A. Marra, N. Hamerschlak, A. Osawa, and M. Scheinberg Aspergillus fumigatus joint infection: a review Semin Arthritis Rheum 40 2011 580 584
76. O.A. Cornely, M. Bassetti, T. Calandra, J. Garbino, B.J. Kullberg, and O. Lortholary et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients Clin Microbiol Infect 18 Suppl. 7 2012 19 37
77. J.H. Rex, J.E. Bennett, A.M. Sugar, P.G. Pappas, J. Serody, and J.E. Edwards et al. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group Clin Infect Dis 21 1995 994 996
78. M. Nucci, E. Anaissie, R.F. Betts, B.F. Dupont, C. Wu, and D.N. Buell et al. Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials Clin Infect Dis 51 2010 295 303
79. N.P. O'Grady, M. Alexander, L.A. Burns, E.P. Dellinger, J. Garland, and S.O. Heard et al. Guidelines for the prevention of intravascular catheter-related infections Clin Infect Dis 52 2011 e162 e193
80. C.J. Walraven, and S.A. Lee Antifungal lock therapy Antimicrob Agents Chemother 57 2013 1 8
81. P.M. Arnow, and R. Kushner Malassezia furfur catheter infection cured with antibiotic lock therapy Am J Med 90 1991 128 130
82. D.C. Johnson, F.L. Johnson, and S. Goldman Preliminary results treating persistent central venous catheter infections with the antibiotic lock technique in pediatric patients Pediatr Infect Dis J 13 1994 930 931
83. E.A. Krzywda, D.A. Andris, C.E. Edmiston Jr., and E.J. Quebbeman Treatment of Hickman catheter sepsis using antibiotic lock technique Infect Control Hosp Epidemiol 16 1995 596 598
84. J.L. Benoit, G. Carandang, M. Sitrin, and P.M. Arnow Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home Clin Infect Dis 21 1995 1286 1288
85. P. Viale, N. Petrosillo, L. Signorini, M. Puoti, and G. Carosi Should lock therapy always be avoided for central venous catheter-associated fungal bloodstream infections? Clin Infect Dis 33 2001 1947 1948 [author reply 1949-51]
86. A. Angel-Moreno, M. Boronat, M. Bolaños, A. Carrillo, S. González, and J.L. Pérez Arellano Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review J Infect 51 2005 e85 e87
87. C.Y. Wu, and P.I. Lee Antibiotic-lock therapy and erythromycin for treatment of catheter-related Candida parapsilosis and Staphylococcus aureus infections J Antimicrob Chemother 60 2007 706 707
88. E. Castagnola, M.G. Marazzi, A. Tacchella, and R. Giacchino Broviac catheter-related candidemia Pediatr Infect Dis J 24 2005 747
89. B.S. Buckler, R.N. Sams, V.L. Goei, K.R. Krishnan, M.J. Bemis, and D.P. Parker et al. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy Pediatr Infect Dis J 27 2008 762 764
90. H. Ozdemir, A. Karbuz, E. Ciftci, H.U. Dincaslan, E. Ince, and D. Aysev et al. Successful treatment of central venous catheter infection due to Candida lipolytica by caspofungin-lock therapy Mycoses 54 2011 e647 e649
91. R.A. Blackwood, K.C. Klein, L.N. Micel, M.L. Willers, R.J. Mody, and D.H. Teitelbaum et al. Ethanol locks therapy for resolution of fungal catheter infections Pediatr Infect Dis J 30 2011 1105 1107
92. S.P. Bachmann, K. VandeWalle, G. Ramage, T.F. Patterson, B.L. Wickes, and J.R. Graybill et al. In vitro activity of caspofungin against Candida albicans biofilms Antimicrob Agents Chemother 46 2002 3591 3596
93. D.M. Kuhn, T. George, J. Chandra, P.K. Mukherjee, and M.A. Ghannoum Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins Antimicrob Agents Chemother 46 2002 1773 1780
94. E. Cateau, J.M. Berjeaud, and C. Imbert Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone Int J Antimicrob Agents 37 2011 380 384
95. E. Cateau, M.H. Rodier, and C. Imbert In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth J Antimicrob Chemother 62 2008 153 155
96. G. Ramage, A. Jose, L. Sherry, D.F. Lappin, B. Jones, and C. Williams Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms Antimicrob Agents Chemother 57 2013 2369 2371
97. M.H. Miceli, S.M. Bernardo, and S.A. Lee In vitro analysis of the occurrence of a paradoxical effect with different echinocandins and Candida albicans biofilms Int J Antimicrob Agents 34 2009 500 502
98. K.S. Ko, J.Y. Lee, J.H. Song, and K.R. Peck In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms J Korean Med Sci 25 2010 1722 1726
99. D. Andes, J. Nett, P. Oschel, R. Albrecht, K. Marchillo, and A. Pitula Development and characterization of an in vivo central venous catheter Candida albicans biofilm model Infect Immun 72 2004 6023 6031
100. S. Kucharikova, H. Tournu, M. Holtappels, P. Van Dijck, and K. Lagrou In vivo efficacy of anidulafungin against mature Candida albicans biofilms in a novel rat model of catheter-associated candidiasis Antimicrob Agents Chemother 54 2010 4474 4475
101. M.K. Schinabeck, L.A. Long, M.A. Hossain, J. Chandra, P.K. Mukherjee, and S. Mohamed et al. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy Antimicrob Agents Chemother 48 2004 1727 1732
102. A.L. Lazzell, A.K. Chaturvedi, C.G. Pierce, D. Prasad, P. Uppuluri, and J.L. Lopez-Ribot Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis J Antimicrob Chemother 64 2009 567 570
103. P.K. Mukherjee, L. Long, H.G. Kim, and M.A. Ghannoum Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms Int J Antimicrob Agents 33 2009 149 153
104. M. Falcone, N. Barzaghi, G. Carosi, P. Grossi, L. Minoli, and V. Ravasio et al. Candida infective endocarditis: report of 15 cases from a prospective multicenter study Medicine (Baltimore) 88 2009 160 168
105. H. Dutronc, F.A. Dauchy, C. Cazanave, C. Rougie, S. Lafarie-Castet, and B. Couprie et al. Candida prosthetic infections: case series and literature review Scand J Infect Dis 42 2010 890 895
106. M.E. Ellis, H. Al-Abdely, A. Sandridge, W. Greer, and W. Ventura Fungal endocarditis: evidence in the world literature, 1965-1995 Clin Infect Dis 32 2001 50 62
107. J.M. Boland, H.H. Chung, F.J. Robberts, W.R. Wilson, J.M. Steckelberg, and L.M. Baddour et al. Fungal prosthetic valve endocarditis: Mayo Clinic experience with a clinicopathological analysis Mycoses 54 2011 354 360
108. L.J. Reis, T.D. Barton, A. Pochettino, O. Velazquez, M. McGarvey, and B. Milas et al. Successful treatment of Aspergillus prosthetic valve endocarditis with oral voriconazole Clin Infect Dis 41 2005 752 753
109. J.J. Deelstra, D. Neut, and P.C. Jutte Successful treatment of Candida albicans-infected total hip prosthesis with staged procedure using an antifungal-loaded cement spacer J Arthroplasty 28 2013 374e5-8
110. B. Johannsson, and J.J. Callaghan Prosthetic hip infection due to Cryptococcus neoformans: case report Diagn Microbiol Infect Dis 64 2009 76 79
111. T. Kelesidis, and S. Tsiodras Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option? Scand J Infect Dis 42 2010 12 21
112. C.L. Cetrulo Jr., A.A. Leto Barone, K. Jordan, D.S. Chang, K. Louie, and R.F. Buntic et al. A multi-disciplinary approach to the management of fungal osteomyelitis: current concepts in post-traumatic lower extremity reconstruction: a case report Microsurgery 32 2012 144 147
113. W. Dai, J.W. Dharamsi, S. Soliman, C. Ricotti, R. Gander, and P. Bergstresser et al. Cutaneous fusariosis developing in a post-irradiation site Dermatol Online J 17 2011 5
114. A.M. Grimoud, J.P. Lodter, N. Marty, S. Andrieu, H. Bocquet, and M.D. Linas et al. Improved oral hygiene and Candida species colonization level in geriatric patients Oral Dis 11 2005 163 169
115. G. Ramage, A. Jose, B. Coco, R. Rajendran, R. Rautemaa, and C. Murray et al. Commercial mouthwashes are more effective than azole antifungals against Candida albicans biofilms in vitro Oral Surg Oral Med Oral Pathol Oral Radiol Endod 111 2011 456 460
116. G. Ramage, A. Zalewska, D.A. Cameron, L. Sherry, C. Murray, and M.B. Finnegan et al. A comparative in vitro study of two denture cleaning techniques as an effective strategy for inhibiting Candida albicans biofilms on denture surfaces and reducing inflammation J Prosthodont 21 2012 516 522
117. A. Jose, B.J. Coco, S. Milligan, B. Young, D.F. Lappin, and J. Bagg et al. Reducing the incidence of denture stomatitis: are denture cleansers sufficient? J Prosthodont 19 2010 252 257
118. R. Rautemaa, M. Richardson, M. Pfaller, P. Koukila-Kahkola, J. Perheentupa, and H. Saxen Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients J Antimicrob Chemother 60 2007 889 892
119. R. Rajendran, C. Williams, D.F. Lappin, O. Millington, M. Martins, and G. Ramage Extracellular DNA release acts as an antifungal resistance mechanism in mature Aspergillus fumigatus biofilms Eukaryot Cell 12 2013 420 429
120. G. Pulcrano, D. Panellis, G. De Domenico, F. Rossano, and M.R. Catania Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm FEMS Yeast Res 12 2012 430 438
121. S. Aslam, and R.O. Darouiche Role of antibiofilm-antimicrobial agents in controlling device-related infections Int J Artif Organs 34 2011 752 758
122. F. Bugli, B. Posteraro, M. Papi, R. Torelli, A. Maiorana, and F. Paroni Sterbini et al. In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods Antimicrob Agents Chemother 57 2013 1275 1282
123. D.R. Monteiro, L.F. Gorup, S. Silva, M. Negri, E.R. de Camargo, and R. Oliveira et al. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata Biofouling 27 2011 711 719
124. D.R. Monteiro, S. Silva, M. Negri, L.F. Gorup, E.R. de Camargo, and R. Oliveira et al. Silver colloidal nanoparticles: effect on matrix composition and structure of Candida albicans and Candida glabrata biofilms J Appl Microbiol 114 2013 1175 1183
125. G. Humphreys, G.L. Lee, S.L. Percival, and A.J. McBain Combinatorial activities of ionic silver and sodium hexametaphosphate against microorganisms associated with chronic wounds J Antimicrob Chemother 66 2011 2556 2561
126. D.R. Monteiro, L.F. Gorup, A.S. Takamiya, E.R. de Camargo, A.C. Filho, and D.B. Barbosa Silver distribution and release from an antimicrobial denture base resin containing silver colloidal nanoparticles J Prosthodont 21 2012 7 15
127. J.S. Kim, E. Kuk, K.N. Yu, J.H. Kim, S.J. Park, and H.J. Lee et al. Antimicrobial effects of silver nanoparticles Nanomedicine 3 2007 95 101
128. R.P. Carlson, R. Taffs, W.M. Davison, and P.S. Stewart Anti-biofilm properties of chitosan-coated surfaces J Biomater Sci Polym Ed 19 2008 1035 1046
129. L.R. Martinez, M.R. Mihu, M. Tar, R.J. Cordero, G. Han, and A.J. Friedman et al. Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model J Infect Dis 201 2010 1436 1440
130. L.R. Martinez, M.R. Mihu, G. Han, S. Frases, R.J. Cordero, and A. Casadevall et al. The use of chitosan to damage Cryptococcus neoformans biofilms Biomaterials 31 2010 669 679
131. C.F. Carson, K.A. Hammer, and T.V. Riley Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties Clin Microbiol Rev 19 2006 50 62
132. K. De Prijck, N. De Smet, K. Honraet, S. Christiaen, T. Coenye, and E. Schacht et al. Inhibition of Candida albicans biofilm formation by antimycotics released from modified polydimethyl siloxane Mycopathologia 169 2010 167 174
133. G. Ramage, S. Milligan, D.F. Lappin, L. Sherry, P. Sweeney, and C. Williams et al. Antifungal, cytotoxic, and immunomodulatory properties of tea tree oil and its derivative components: potential role in management of oral candidosis in cancer patients Front Microbiol 3 2012 220
134. C.C. Hsu, W.L. Lai, K.C. Chuang, M.H. Lee, and Y.C. Tsai The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans Med Mycol 51 2013 473 482
135. L. Sherry, A. Jose, C. Murray, C. Williams, B. Jones, and O. Millington et al. Carbohydrate derived fulvic acid: an in vitro investigation of a novel membrane active antiseptic agent against Candida albicans biofilms Front Microbiol 3 2012 116
136. Y. Rukayadi, and J.K. Hwang In vitro activity of xanthorrhizol isolated from the rhizome of Javanese turmeric (Curcuma xanthorrhiza Roxb.) against Candida albicans biofilms Phytother Res 27 2013 1061 1066
137. J.C. Sardi, L. Scorzoni, T. Bernardi, A.M. Fusco-Almeida, and M.J. Mendes Giannini Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options J Med Microbiol 62 2013 10 24
138. C. Oliveira, A. Nasr, M. Brindle, and P.W. Wales Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis Pediatrics 129 2012 318 329
139. K.P. Pieroni, C. Nespor, R.L. Poole, J.A. Kerner Jr., and W.E. Berquist Echinocandin and ethanol lock therapy treatment of fungal catheter infections Pediatr Infect Dis J 32 2013 289 291
140. H.J. Busscher, C.G. van Hoogmoed, G.I. Geertsema-Doornbusch, M. van der Kuijl-Booij, and H.C. van der Mei Streptococcus thermophilus and its biosurfactants inhibit adhesion by Candida spp. on silicone rubber Appl Environ Microbiol 63 1997 3810 3817
141. A. Murzyn, A. Krasowska, P. Stefanowicz, D. Dziadkowiec, and M. Lukaszewicz Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation PLoS ONE 5 2010 e12050
142. L. Rodrigues, H. van der Mei, I.M. Banat, J. Teixeira, and R. Oliveira Inhibition of microbial adhesion to silicone rubber treated with biosurfactant from Streptococcus thermophilus A FEMS Immunol Med Microbiol 46 2006 107 112
143. L. Rodrigues, H. van der Mei, J.A. Teixeira, and R. Oliveira Biosurfactant from Lactococcus lactis 53 inhibits microbial adhesion on silicone rubber Appl Microbiol Biotechnol 66 2004 306 311
144. X. Wang, L. Du, J. You, J.B. King, and R.H. Cichewicz Fungal biofilm inhibitors from a human oral microbiome-derived bacterium Org Biomol Chem 10 2012 2044 2050
145. P.M. Joyner, J. Liu, Z. Zhang, J. Merritt, F. Qi, and R.H. Cichewicz Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition Org Biomol Chem 8 2010 5486 5489
146. G. Ramage, S.P. Saville, B.L. Wickes, and J.L. López-Ribot Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule Appl Environ Microbiol 68 2002 5459 5463
147. P. Albuquerque, and A. Casadevall Quorum sensing in fungi - a review Med Mycol 50 2012 337 345
148. D.H. Navarathna, J.M. Hornby, N. Krishnan, A. Parkhurst, G.E. Duhamel, and K.W. Nickerson Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans Infect Immun 75 2007 1609 1618